Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Inflammation × CHR 2845 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Inflammation 1 Carcinoma, Hepatocellular 1

Interventions

Vitamin D 1 CHR 2845 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02759601 2018-12-20

CHR-2845

Queen Mary University of London

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡